1. Summary of product characteristics - KAFTRIO,2020
2. Therapeutic drug monitoring of ivacaftor, lumacaftor, tezacaftor, and elexacaftor in cystic fibrosis: where are we now?;Choong;Pharmaceutics,2022
3. CFTR modulators: does one dose fit all?;van der Meer;J Pers Med,2021
4. Stepwise introduction of elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and liver cirrhosis child-Pugh A or B using clinical and therapeutic drug monitoring: a case series;Vonk;Clin Ther,2023
5. A quantitative method for the analysis of ivacaftor, hydroxymethyl ivacaftor, ivacaftor carboxylate, lumacaftor, and tezacaftor in plasma and sputum using LC-MS/MS and its clinical applicability;Vonk;Ther Drug Monit,2020